Diet-induced macrophage inhibitory cytokine 1 promotes prostate cancer progression

Endocrine-Related Cancer

Volumn 21, Issue 1, 2014, Pages 39-50

  Huang, Mingguo ^a,b   Narita, Shintaro ^a,b   Inoue, Takamitsu ^a   Tsuchiya, Norihiko ^a,b   Satoh, Shigeru ^a   Nanjo, Hiroshi ^a   Sasaki, Takehiko ^a,b   Habuchi, Tomonori ^a,b  

^a AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

High fat diet; Macrophage inhibitory cytokine 1; Palmitic acid; Prostate cancer

Indexed keywords

FATTY ACID; GROWTH DIFFERENTIATION FACTOR 15; NEUTRALIZING ANTIBODY; PALMITIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER SURGERY; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT INTAKE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; LOW FAT DIET; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OBESITY; PROSTATE CANCER; PROSTATECTOMY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; TUMOR INVASION; TUMOR PROMOTION; TUMOR XENOGRAFT; UPREGULATION; VENULE;

HIGH-FAT DIET; MACROPHAGE INHIBITORY CYTOKINE 1; PALMITIC ACID; PROSTATE CANCER;

AGED; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; DIET, HIGH-FAT; DIETARY FATS; FATTY ACIDS, NONESTERIFIED; GROWTH DIFFERENTIATION FACTOR 15; HISTOCYTOCHEMISTRY; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; PALMITIC ACID; PROSTATIC NEOPLASMS; RANDOM ALLOCATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; RNA, SMALL INTERFERING; STATISTICS, NONPARAMETRIC;

EID: 84893621838     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0227     Document Type: Article

References (40)

1. Andersson SO, Wolk A, Bergstrom R, Adami HO, Engholm G, Englund A & Nyren O 1997 Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. Journal of the National Cancer Institute 89 385-389. (doi:10.1093/jnci/89.5.385)
2. Bauskin AR, Brown DA, Junankar S, Rasiah KK, Eggleton S, Hunter M, Liu T, Smith D, Kuffner T, Pankhurst GJ et al. 2005 The propeptide mediates formation of stromal stores of PROMIC-1: role in determining prostate cancer outcome. Cancer Research 65 2330-2336. (doi:10.1158/0008-5472.CAN-04-3827)
3. Blair A & Fraumeni JF 1978 Geographic patterns of prostate cancer in the United States. Journal of the National Cancer Institute 61 1379-1384.
4. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY, Zhang HP, Donnellan M, Mahler S, Pryor K et al. 1997 MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-b superfamily. PNAS 94 11514-11519. (doi:10.1073/pnas.94.21.11514)
5. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ, Bauskin AR, Kinzler KW, Vogelstein B & Breit SN 2003 MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clinical Cancer Research 9 2642-2650.
6. Brown DA, Stephan C, Ward RL, Law M, Hunter M, Bauskin AR, Amin J, Jung K, Diamandis EP, Hampton GM et al. 2006 Measurement of serum levels of macrophage inhibitory cytokine 1 combined with prostatespecific antigen improves prostate cancer diagnosis. Clinical Cancer Research 12 89-96. (doi:10.1158/1078-0432.CCR-05-1331)
7. Brown DA, Lindmark F, Stattin P, Balter K, Adami HO, Zheng SL, Xu J, Isaacs WB, Gronberg H, Breit SN et al. 2009 Macrophage inhibitory cytokine 1: a new prognostic marker in prostate cancer. Clinical Cancer Research 15 6658-6664. (doi:10.1158/1078-0432.CCR-08-3126)
8. Chen SJ, Karan D, Johansson SL, Lin FF, Zeckser J, Singh AP, Batra SK & Lin MF 2007 Prostate-derived factor as a paracrine and autocrine factor for the proliferation of androgen receptor-positive human prostate cancer cells. Prostate 67 557-571. (doi:10.1002/pros.20551)
9. Cortez M, Carmo LS, Rogero MM, Borelli P & Fock RA 2013 A high-fat diet increases IL-1, IL-6, and TNF-α production by increasing NF-κB and attenuating PPAR-γ expression in bone marrow mesenchymal stem cells. Inflammation 36 379-386. (doi:10.1007/s10753-012-9557-z)
10. Degeorges A, Hoffschir F, Cussenot O, Gauville C, Le Duc A, Dutrillaux B & Calvo F 1995 Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line. International Journal of Cancer 62 724-731. (doi:10.1002/ijc.2910620613)
11. Dostalova I, Roubicek T, Bartlova M, Mraz M, Lacinova Z, Haluzikova D, Kavalkova P, Matoulek M, Kasalicky M & Haluzik M 2009 Increased serum concentrations of macrophage inhibitory cytokine-1 in patients with obesity and type 2 diabetes mellitus: the influence of very low calorie diet. European Journal of Endocrinology 161 397-404. (doi:10.1530/EJE-09-0417)
12. Flavin R, Zadra G & Loda M 2011 Metabolic alterations and targeted therapies in prostate cancer. Journal of Pathology 223 283-294. (doi:10.1002/path.2809)
13. Giovannucci E, Rimm EB, Colditz GA, Stampfer MJ, Ascherio A, Chute CC & Willett WC 1993 A prospective study of dietary fat and risk of prostate cancer. Journal of the National Cancer Institute 85 1571-1579. (doi:10.1093/jnci/85.19.1571)
14. Haversen L, Danielsson KN, Fogelstrand L & Wiklund O 2009 Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages. Atherosclerosis 202 382-393. (doi:10.1016/j.atherosclerosis.2008. 05.033)
15. Hromas R, Hufford M, Sutton J, Xu D, Li Y & Lu L 1997 PLAB, a novel placental bone morphogenetic protein. Biochimica et Biophysica Acta: Gene Structure and Expression 1354 40-44. (doi:10.1016/S0167-4781(97)00122-X)
16. Hsing AW & Devesa SS 2001 Trends and patterns of prostate cancer: what do they suggest? Epidemiologic Reviews 23 3-13. (doi:10.1093/ oxfordjournals.epirev.a000792)
17. Huang M, Narita S, Tsuchiya N, Ma Z, Numakura K, Obara T, Tsuruta H, Saito M, Inoue T, Horikawa Y et al. 2011 Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome. Carcinogenesis 32 1589-1596. (doi:10.1093/carcin/ bgr182)
18. Huang M, Narita S, Numakura K, Tsuruta H, Saito M, Inoue T, Horikawa Y, Tsuchiya N & Habuchi T 2012 A high-fat diet enhances proliferation of prostate cancer cells and activates MCP-1/CCR2 signaling. Prostate 72 1779-1788. (doi:10.1002/pros.22531)
19. Husaini Y, Qiu MR, Lockwood GP, Luo XW, Shang P, Kuffner T, Tsai VW, Jiang L, Russell PJ, Brown DA et al. 2012 Macrophage inhibitory cytokine-1 (MIC-1/GDF15) slows cancer development but increases metastases in TRAMP prostate cancer prone mice. PLoS ONE 7 e43833. (doi:10.1371/journal.pone. 0043833)
20. Johnen H, Lin S, Kuffner T, Brown DA, Tsai VW, Bauskin AR, Wu L, Pankhurst G, Jiang L, Junankar S et al. 2007 Tumor-induced anorexia and weight loss are mediated by the TGF-b superfamily cytokine MIC-1. Nature Medicine 13 1333-1340. (doi:10.1038/nm1677)
21. Karczewska-Kupczewska M, Kowalska I, Nikolajuk A, Adamska A, Otziomek E, Gorska M & Straczkowski M 2012 Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity. Clinical Endocrinology 76 46-50. (doi:10.1111/j.1365-2265.2011.04139.x)
22. Kim JH, Kim KY, Jeon JH, Lee SH, Hwang JE, Lee JH, Kim KK, Lim JS, Kim KI, Moon EY et al. 2008a Adipocyte culture medium stimulates production of macrophage inhibitory cytokine 1 in MDA-MB-231 cells. Cancer Letters 261 253-262. (doi:10.1016/j.canlet.2007.11.020)
23. Kim KK, Lee JJ, Yang Y, You KH & Lee JH 2008b Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells. Carcinogenesis 29 704-712. (doi:10.1093/carcin/ bgn031)
24. Koopmann J, Buckhaults P, Brown DA, Zahurak ML, Sato N, Fukushima N, Sokoll LJ, Chan DW, Yeo CJ, Hruban RH et al. 2004 Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers. Clinical Cancer Research 10 2386-2392. (doi:10.1158/1078-0432.CCR-03-0165)
25. Kurahashi N, Inoue M, Iwasaki M, Sasazuki S & Tsugane AS 2008 Dairy product, saturated fatty acid, and calcium intake and prostate cancer in a prospective cohort of Japanese men. Cancer Epidemiology, Biomarkers & Prevention 17 930-937. (doi:10.1158/1055-9965. EPI-07-2681)
26. Macia L, Tsai VW, Nguyen AD, Johnen H, Kuffner T, Shi YC, Lin S, Herzog H, Brown DA, Breit SN et al. 2012 Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets. PLoS ONE 7 e34868. (doi:10.1371/journal.pone. 0034868)
27. Namiki M, Akaza H, Lee SE, Song JM, Umbas R, Zhou L, Lee BC, Cheng C, Chung MK, Fukagai T et al. 2010 Prostate Cancer Working Group report. Japanese Journal of Clinical Oncology 40 (Suppl 1) i70-i75. (doi:10.1093/jjco/hyq130)
28. Narita S, Tsuchiya N, Saito M, Inoue T, Kumazawa T, Yuasa T, Nakamura A & Habuchi T 2008 Candidate genes involved in enhanced growth of human prostate cancer under high fat feeding identified by microarray analysis. Prostate 68 321-335. (doi:10.1002/pros.20681)
29. Oberbach A, Schlichting N, Bluher M, Kovacs P, Till H, Stolzenburg JU & Neuhaus J 2010 Palmitate induced IL-6 and MCP-1 expression in human bladder smooth muscle cells provides a link between diabetes and urinary tract infections. PLoS ONE 5 e10882. (doi:10.1371/journal.pone.0010882)
30. Paralkar VM, Vail AL, Grasser WA, Brown TA, Xu H, Vukicevic S, Ke HZ, Qi H, Owen TA & Thompson DD 1998 Cloning and characterization of a novel member of the transforming growth factor-b/bone morphogenetic protein family. Journal of Biological Chemistry 273 13760-13767. (doi:10.1074/jbc.273.22.13760)
31. Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK & Batra SK 2010 Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene 29 1293-1302. (doi:10.1038/onc.2009.420)
32. Shim M & Eling TE 2005 Protein kinase C-dependent regulation of NAG-1/placental bone morphogenic protein/MIC-1 expression in LNCaP prostate carcinoma cells. Journal of Biological Chemistry 280 18636-18642. (doi:10.1074/jbc.M414613200)
33. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE & Mack TM 1991 Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. British Journal of Cancer 63 963-966. (doi:10.1038/bjc.1991. 210)
34. Strom SS, Yamamura Y, Forman MR, Pettaway CA, Barrera SL & DiGiovanni J 2008 Saturated fat intake predicts biochemical failure after prostatectomy. International Journal of Cancer 122 2581-2585. (doi:10.1002/ijc.23414)
35. Tete S, Nicoletti M, Saggini A, Maccauro G, Rosati M, Conti F, Cianchetti E, Tripodi D, Toniato E, Fulcheri M et al. 2012 Nutrition and cancer prevention. International Journal of Immunopathology and Pharmacology 25 573-581.
36. Tominaga S 1985 Cancer incidence in Japanese in Japan, Hawaii, and western United States. National Cancer Institute Monographs 69 83-92.
37. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ & Ting JP 2011 Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nature Immunology 12 408-415. (doi:10.1038/ni.2022)
38. Wollmann W, Goodman ML, Bhat-Nakshatri P, Kishimoto H, Goulet RJ Jr, Mehrotra S, Morimiya A, Badve S & Nakshatri H 2005 The macrophage inhibitory cytokine integrates AKT/PKB and MAP kinase signaling pathways in breast cancer cells. Carcinogenesis 26 900-907. (doi:10.1093/carcin/bgi031)
39. Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S & Chung LW 1994 Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. International Journal of Cancer 57 406-412. (doi:10.1002/ijc.2910570319)
40. Zeng L, Wu GZ, Goh KJ, Lee YM, Ng CC, You AB, Wang J, Jia D, Hao A, Yu Q et al. 2008 Saturated fatty acids modulate cell response to DNA damage: implication for their role in tumorigenesis. PLoS ONE 3 e2329. (doi:10.1371/journal.pone.0002329)